JPRN-jRCT1080225227已完成1 期
Randomized, placebo-controlled, double-blind, single-centre, Phase 1 trial to investigate tolerability, safety, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of SCO-094 subcutaneously administered in patients with type 2 diabetes
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 85age old（—）
- 性别
- All
入选标准
- •Type 2 diabetic Caucasian male or females will be included if they are aged between 18 and 65 (inclusive), with a body mass index (BMI) between 18.0 and 35.0 kg/m2.
- •Patients must be stable and treated with either diet and exercise alone or an anti-glycaemic monotherapy (metformin, DPP-4i, pioglitazone, an SU or an SGLT-2i). Patients must agree to use effective methods of contraception.
排除标准
- •Patients treated with insulin such as type 1 diabetes or evidence of C-peptide deficiency and patients with
- •current or recurrent disease; e.g., cardiovascular, haematological, neurological, endocrine, immunological, renal, hepatic or gastrointestinal or other conditions)
- •that could affect the action, absorption, or disposition of SCO-094, or could affect clinical assessments or clinical laboratory evaluations.
研究者
相似试验
进行中（未招募）
1 期
Influenza virus challenge study to test monocloncal antibody CT-P27 as a treatment for influenza (flu)MedDRA version: 16.1Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsInfluenzaEUCTR2013-004544-32-GBCelltrion, Inc
已完成
不适用
Randomised, double-blind, placebo-controlled, single-dose, dose-escalation study of the safety, tolerability, and pharmacokinetics of Lu AA24493 in acute ischemic strokeischemic stroke10007963NL-OMON31272undbeck5
尚未招募
2 期
Safety, tolerability and pharmacokinetics of SSTK-101 in healthy volunteersACTRN12624001064594SKYDD Biotechnology Pty Ltd38
已完成
不适用
Double-blind, placebo-controlled, randomized, single-ascending dose study to investigate the tolerability, safety, pharmacokinetics, pharmacodynamics, absolute bioavailability, mass balance, and metabolism of ACT-541468 in healthy male subjectsSleep disordersSleeping disordersinsomniaNL-OMON41910Actelion Pharmaceuticals56
进行中（未招募）
1 期
Exploratory Clinical Trial to Investigate Safety and Efficacy of COMBOPROFEN for treatment of muscular pain associated with DOMSEUCTR2016-003139-39-ESSpherium Biomed